saxifragifolin B

has antineoplastic activity; isolated from Androsace umbellata; structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Carcinoma (Carcinomatosis) 09/01/2014 - "This study showed the remarkable cytotoxic activity of saxifragifolin B, especially against breast adenocarcinoma and lung carcinoma and its chemoprotective activity against mitomycin C. " 09/01/2014 - "Saxifragifolin B was found to be 56- and 37-times more active than mitomycin C against breast adenocarcinoma (SK-BR-3) and lung carcinoma (NCI-H1299), respectively. "
2.	Adenocarcinoma 09/01/2014 - "This study showed the remarkable cytotoxic activity of saxifragifolin B, especially against breast adenocarcinoma and lung carcinoma and its chemoprotective activity against mitomycin C. " 09/01/2014 - "Saxifragifolin B was found to be 56- and 37-times more active than mitomycin C against breast adenocarcinoma (SK-BR-3) and lung carcinoma (NCI-H1299), respectively. "
3.	Hepatocellular Carcinoma (Hepatoma) 10/26/2007 - "Saxifragifolin B from Androsace umbellata induced apoptosis on human hepatoma cells."

1.	Mitomycin (Mitomycin-C)